DOI: https://doi.org/10.30841/2307-5112.5(73).2017.123019

Angioprotection: brain vessels’ protection in family medicine’s practice

С. Г. Бурчинський

Abstract


In the present paper the role of cerebrovascular pathology in a modern medicine and particularly the role of endothelial dysfunction as a one of the main pathogenetical mechanisms of brain vessels’ disturbances and ischemia of central nervous system has been  looked. Based on this point of view, the requirements to choice of optimal pharmacological strategy concerning correction of brain pathological changes during ischemia, and particularly pharmacotherapy’ advantages using L-arginine have been analyzed. A  main attention paid to clinico-pharmacological effects of drug Tivomax, and possibilities of pathogenetically grounding of angioprotection and neuroprotection. A clinical efficacy of Mexiprim and peculiarities of it’s dosage regimen’s have been looked in detail.

Keywords


cerebrovascular disturbances; endothelial dysfunction; angioprotection; neuroprotection; L-arginine; Tivomax

References


Бабушкина А.В. L-аргинин с точки зрения доказательной медицины // Укр. мед. часопис. – 2009. – No 6. – С. 43–48.

Калашников В.И. Диагностика и коррекция эндотелиальной дисфункции у пациентов с дисциркуляторной энцефалопатией // Здоров’я України. – 2017. – No 2. – С. 27–28.

Мищенко Т.С. Эпидемиология цереброваскулярных заболеваний и организация помощи больным с мозговым инсультом в Украине // Укр. вісн. психоневрол. – 2017. – Т. 25, вип. 1. – С. 22–24.

Товажнянская Е.Л. Эндотелиальная дисфункция. Клинические аспекты проблемы и пути ее решения // Журн. неврол. им. Н.Б. Маньковского. – 2016. – No 3. – С. 17–21.

Трещинская М.А. Теоретические и практические аспекты применения L аргинина с целью профилактики цереброваскулярной патологии // Укр. мед. часопис. – 2011. – No 5. – С. 97–109.

Boger R.H. The pharmacodynamics of L-arginine // J. Nutr. – 2007. – V. 137. – P. 1650S–1655S.

Briasoulis A., Tousoulis D., Androulakis E.S. et al. Endothelial dysfunction and atherosclerosis: focus on novel therapeutic approaches // Recent Pat. Cardiovasc. Drug Discov. – 2012. – V. 7. – P. 21–32.

Cooke J.P. The endothelium: a new target for therapy // Vasc. Med. – 2000. – V. 5. – P. 49–53.

Loscalzo J. L arginine and atherotrombosis // J. Nutr. – 2004. – V. 134. – P. 2896–2897.

Lyons C.R. The role of nitric oxide in inflammation // Adv. Immunol. – 1995. – V. 60. – P. 323–371.




Copyright (c) 2020 С. Г. Бурчинський

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

ISSN 2412-8708 (Online), ISSN 2307-5112 (Print)

Flag Counter

ISSN (print): 2307-5112.